Welcome to the Journal
The scope of the journal encompass a broad range of topics including translational science research, genetics, immunology, nutrition, psychosocial research, epidemiology and multidisciplinary team approaches towards imparting quality healthcare services. The journal also welcomes articles written by doctors, physicians and medical giants that present their personal perspectives in treating commonly as well as rarely occurring diseases. The journal invites submission of Phase III clinical trial results as well as outcomes from phase IV/post-marketing studies on novel drugs used in clinical practice. Furthermore, manuscripts describing multiple facets of diabetes research and clinical practice, prevention, technologies and therapy, socio-economic research, complications, new treatments, evidence-based treatment guidelines, unmet clinical needs and therapeutic burden are solicited. Overall, the journal targets promotion of safe and efficacious clinical practices by publishing original data from clinical investigations. You may submit manuscripts online at https://www.scholarscentral.org/submissions/clinical-practice-therapy.html or as an email attachment to [email protected]
Clinical Practice(Therapy) is indexed in the quality indexing sites such as Scopus*, EMBASE/Excerpta Medica, Google Scholar, Publons, CNKI, Open J-Gate to standardized visibility and maintain publication standard.
*Published as Therapy (ISSN 1475-0708) until November 2011 (Vol.8, No.6)
Recently Published Articles
Review Article p. 1466-1477
Pharmacovigilance, international classification of diseases and adverse reaction reporting tools used in United States of America and Europe
Author(s): Nikhil Gupta, Kavita Bahmani and Ajit Jangra
Adverse Drug Reaction (ADR) identification is the most important goal during the post marketing phase. ADR identification is needed for the surveillance of drug safety. The spontaneous repor..
Author(s): Elizabeth Swan